Navigation Links
Today's Research: Life Technologies, Opko Health, Medicines, and DaVita

LONDON, July 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, July 24, 2013, shares in the healthcare sector ended mostly lower, tracking the broader market which also closed in the red. The major movers in the sector included Life Technologies Corp. (NASDAQ: LIFE), Opko Health Inc. (NYSE: OPK), The Medicines Company (NASDAQ: MDCO), and DaVita Healthcare Partners Inc. (NYSE: DVA). has completed their technical analysis on LIFE, OPK, MDCO, and DVA and these free reports are accessible by registering at:  

Shares in Life Technologies Corp. ended slightly lower on Wednesday, finishing at $74.52, down 0.07% from its previous closing price. The company's shares fluctuated between $74.52 and $74.73. A total of 1.69 million shares were traded which is below the daily average volume of 1.79 million. Life Technologies' shares are currently trading near their 52-week high of $74.81. The stock has gained 0.70% in the last one month and 1.11% in the last three months. Sign up for free technical research on LIFE at:

Opko Health Inc.'s stock fell sharply on Wednesday, tracking losses in the broader market. The company's shares ended the day 1.94% lower at $7.57 after fluctuating between $7.47 and $7.77. A total of 1.86 million shares were traded which is above the daily average volume of 1.53 million. Despite Wednesday's pullback, Opko Health's shares have gained 9.39% in the last one month and 8.76% in the last three months, hence outperforming the S&P 500 during the respective periods. Moreover, the stock is currently trading near its 52-week high of $7.83. Be sure to read our latest technical research on OPK by registering at:

Shares in The Medicines Company tumbled on Wednesday, ending the session 5.05% lower at $29.73 after fluctuating between $29.52 and $32.60. A total of 1.81 million shares were traded which is below the daily average volume of 758,839. The company's shares have fallen by 7.18% in the last one month and 11.15% in the last three months as compared to a gain of 7.17% and 6.79% in the S&P 500 during the respective periods. The stock is trading above its 200-day moving average. Sign up and read the complimentary report on MDCO at:

DaVita Healthcare Partners Inc.'s stock edged lower on Wednesday, tracking losses in the broader market. The company's shares oscillated between $117.04 and $118.97. A total of 538,902 shares were traded which is below the daily average volume of 1.00 million. DaVita's shares have fallen by 4.43% in the last one month and 3.56% in the last three months. However, the stock is trading slightly above its 200-day moving average. The free report on DVA can be downloaded by signing up now at:



  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at
  5. For any urgent concerns or inquiries, please contact us at
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to for consideration.


Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.


Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.


Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
2. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
3. Graphene Research: Trapping light in a carbon net
4. A milestone in nanoparticle research: Nanoparticle test handbook sets the standards
5. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
6. Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
7. DNA Sequencing: Technologies, Markets and Companies - 2013 Report
8. Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
9. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
10. Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
11. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
Post Your Comments:
(Date:10/13/2015)... and TORONTO , Oct. 13, 2015 ... announced that it has entered into a non-binding Letter of ... private Israeli company that has developed a proprietary cooling technology ... to varicoceles. the United States ... between the ages of 25 and 44 diagnosed as infertile.  ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed ... growing clinical data solutions business. , Jeff Parr has spent the past decade providing ... Avery Dennison, Thermo Fisher, and Ab Sciex to name a few. He is ...
(Date:10/13/2015)... ... ... Proove Biosciences, a commercial and research leader ... Medicine of the University of Southern California (USC) Pain Center to study ... Clinical Objectives Linking Genotypic and Phenotypic Association with Pain Outcomes) is one of ...
(Date:10/13/2015)... the United States , Canada ... 14% of all new cases of kidney cancer.   --> ... and Europe .  PRCC represents about 14% ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison ... ("AstraZeneca") have completed enrolment in a global Phase II study of ...
Breaking Biology Technology:
(Date:10/6/2015)... MATEO, Calif. , Oct. 6, 2015 /PRNewswire/ ... company, today announced enhancements to its software portfolio ... expression analysis kit for differential expression in eukaryotes. ... Platform, which is a cloud-based genomic analysis solution ... advance scientific discovery from next-generation sequencing efforts. ...
(Date:9/30/2015)... SACRAMENTO, Calif. , Sept. 30, 2015  With ... and the number of new SCIs estimated to reach ... like Southern California Resource Services for Independent Living ... 28 ILCs in California opening ... a range of programs and services, notably assistive technology ...
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
Breaking Biology News(10 mins):